Harvard Catalyst Profiles

Contact, publication, and social network information about Harvard faculty and fellows.

David Zurakowski, Ph.D.

Co-Author

This page shows the publications co-authored by David Zurakowski and Arin Greene.
Connection Strength

1.812
  1. Body Mass Index and Lymphedema Morbidity: Comparison of Obese versus Normal-Weight Patients. Plast Reconstr Surg. 2020 08; 146(2):402-407.
    View in: PubMed
    Score: 0.230
  2. Body Mass Index and Lymphedema Morbidity: Comparison of Obese Versus Normal-Weighted Patients. Plast Reconstr Surg. 2020 Apr 27.
    View in: PubMed
    Score: 0.226
  3. Correlation Between Lymphedema Disease Severity and Lymphoscintigraphic Findings: A Clinical-Radiologic Study. J Am Coll Surg. 2017 Sep; 225(3):366-370.
    View in: PubMed
    Score: 0.186
  4. Massive Localized Lymphedema: A Case-Control Study. J Am Coll Surg. 2017 Feb; 224(2):212-216.
    View in: PubMed
    Score: 0.178
  5. Infantile hemangioma: clinical assessment of the involuting phase and implications for management. Plast Reconstr Surg. 2012 Sep; 130(3):619-624.
    View in: PubMed
    Score: 0.133
  6. Expression of androgen, estrogen, progesterone, and growth hormone receptors in vascular malformations. Plast Reconstr Surg. 2012 Jun; 129(6):919e-924e.
    View in: PubMed
    Score: 0.130
  7. Venous malformation: risk of progression during childhood and adolescence. Ann Plast Surg. 2012 Feb; 68(2):198-201.
    View in: PubMed
    Score: 0.128
  8. Lymphatic malformation: risk of progression during childhood and adolescence. J Craniofac Surg. 2012 Jan; 23(1):149-52.
    View in: PubMed
    Score: 0.127
  9. Primary lymphedema: clinical features and management in 138 pediatric patients. Plast Reconstr Surg. 2011 Jun; 127(6):2419-2431.
    View in: PubMed
    Score: 0.122
  10. Extracranial arteriovenous malformations: natural progression and recurrence after treatment. Plast Reconstr Surg. 2010 Apr; 125(4):1185-1194.
    View in: PubMed
    Score: 0.112
  11. Determining the need for simulated training of invasive procedures. Adv Health Sci Educ Theory Pract. 2006 Feb; 11(1):41-9.
    View in: PubMed
    Score: 0.084
  12. Prevention of intra-abdominal adhesions using the antiangiogenic COX-2 inhibitor celecoxib. Ann Surg. 2005 Jul; 242(1):140-6.
    View in: PubMed
    Score: 0.081
  13. Lymphatic and other vascular malformative/overgrowth disorders are caused by somatic mutations in PIK3CA. J Pediatr. 2015 Apr; 166(4):1048-54.e1-5.
    View in: PubMed
    Score: 0.039
  14. PIK3CA activating mutations in facial infiltrating lipomatosis. Plast Reconstr Surg. 2014 Jan; 133(1):12e-19e.
    View in: PubMed
    Score: 0.036
Connection Strength
The connection strength for co-authors is the sum of the scores for each of their shared publications.

Publication scores are based on many factors, including how long ago they were written and whether the person is a first or senior author.
Funded by the NIH National Center for Advancing Translational Sciences through its Clinical and Translational Science Awards Program, grant number UL1TR002541.